🇺🇸 FDA
Pipeline program

PEMBROLIZUMAB, PM54

PM54-A-003-25

Phase 2 small_molecule active

Quick answer

PEMBROLIZUMAB, PM54 for Advanced malignancies is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Advanced malignancies
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials